Stock 4168 GLYCONEX INCORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News GlycoNex Incorporation

Equities

4168

TW0004168000

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 06/06/2024 BST 		5-day change 1st Jan Change
27.15 TWD +0.74% Intraday chart for GlycoNex Incorporation +5.85% -8.74%
05-28 Glyconex and Precisemab Sign Technology Licensing Agreement to Advance Development of Novel Anti-Glycan Antibodies for Cancer Therapy CI
05-14 GlycoNex Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Glyconex and Precisemab Sign Technology Licensing Agreement to Advance Development of Novel Anti-Glycan Antibodies for Cancer Therapy
CI
GlycoNex Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
GlycoNex Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
GlycoNex Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
GlycoNex Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
GlycoNex Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
GlycoNex Incorporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
GlycoNex Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
GlycoNex Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
GlycoNex Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
GlycoNex Incorporation Reports Earnings Results for the Full Year Ended December 31, 2021
CI
GlycoNex Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Glyconex Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Glyconex Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Glyconex Incorporation Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Glyconex Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2020
CI
Glyconex Incorporation Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
Glyconex Incorporation Reports Earnings Results for the Full Year Ended December 31, 2019
CI
Glyconex Incorporation Reports Earnings Results for the Third Quarter Ended September 30, 2019
CI
Glyconex Incorporation Reports Earnings Results for the Second Quarter Ended June 30, 2019
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4168 Stock
  4. News GlycoNex Incorporation
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW